NTHI · NeOnc Technologies Holdings Inc. Common Stock
View on chartInsiders & Stakes
| Amir F. Heshmatpour CEO, President | ▲ Buy | Open Market | 3,183,000 Shares held | 9/15/2026 | View profile |
| Ming-Fu (alan) Chiang | ▼ Sell | Other | 324,688 Shares held | 3/26/2025 | View profile |
| Keithly Garnett CFO | ▼ Sell | Open Market | 237,357 Shares held | 9/15/2026 | View profile |
| Yousha Neman-Ebrahim Chief Clinical Officer | ▲ Buy | Open Market | 134,760 Shares held | 4/23/2026 | View profile |
| SUH, DAVID JR. Chief Accounting Officer | ▲ Buy | Open Market | 111,866 Shares held | 4/9/2026 | View profile |
| Patrick Walters COO | ▼ Sell | Other | 66,669 Shares held | 3/26/2025 | View profile |
| Jim Delshad | ▲ Buy | Open Market | 55,310 Shares held | 5/12/2025 | View profile |
| Nasim Shomali Director | ▲ Buy | Grant | 50,160 Shares held | 7/10/2026 | View profile |
| Steven L. Giannotta | ▲ Buy | Grant | 50,160 Shares held | 3/26/2025 | View profile |
| Thomas C. Chen CEO | ▲ Buy | Open Market | 24,503 Shares held | 9/14/2026 | View profile |
Transaction History
| Amir F. Heshmatpour | ▲ Buy | Open Market | 35,000 | $115K | 9/15/2026 |
| Keithly Garnett | ▼ Sell | Open Market | 5,000 | $17K | 9/15/2026 |
| Thomas C. Chen | ▲ Buy | Open Market | 5,242 | $20K | 9/14/2026 |
| Keithly Garnett | ▲ Buy | Open Market | 257 | $1K | 9/14/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 15,000 | $59K | 9/14/2026 |
| Thomas C. Chen | ▲ Buy | Open Market | 5,556 | $20K | 9/11/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 37,000 | $136K | 9/11/2026 |
| Thomas C. Chen | ▲ Buy | Open Market | 12,757 | $70K | 8/18/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 9,000 | $50K | 8/18/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 3,000 | $13K | 8/17/2026 |
| Thomas C. Chen | ▲ Buy | Open Market | 2,472 | $10K | 8/17/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 12,000 | $45K | 8/14/2026 |
| Thomas C. Chen | ▲ Buy | Open Market | 33,787 | $130K | 8/14/2026 |
| Nasim Shomali | ▲ Buy | Grant | 50,000 | — | 7/10/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 10,000 | $42K | 5/1/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 10,000 | $45K | 4/28/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 10,000 | $49K | 4/23/2026 |
| Yousha Neman-Ebrahim | ▲ Buy | Open Market | 500 | $2K | 4/23/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 10,000 | $49K | 4/10/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 5,000 | $26K | 4/9/2026 |
| SUH, DAVID JR. | ▲ Buy | Open Market | 200 | $1K | 4/9/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 10,000 | $56K | 4/8/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 5,000 | $32K | 4/6/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 20,000 | $122K | 4/2/2026 |
| SUH, DAVID JR. | ▲ Buy | Grant | 111,666 | — | 3/1/2026 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 6,000 | $39K | 11/24/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 20,000 | $120K | 11/21/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 4,000 | $26K | 11/21/2025 |
| Yousha Neman-Ebrahim | ▲ Buy | Open Market | 1,100 | $7K | 11/20/2025 |
| Amir F. Heshmatpour | ▲ Buy | Grant | 1,200,000 | — | 11/6/2025 |
| Yousha Neman-Ebrahim | ▲ Buy | Grant | 133,000 | — | 6/5/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 2,000 | $15K | 5/23/2025 |
| Thomas C. Chen | ▲ Buy | Open Market | 2,709 | $20K | 5/22/2025 |
| Keithly Garnett | ▲ Buy | Open Market | 675 | $5K | 5/22/2025 |
| Thomas C. Chen | ▲ Buy | Open Market | 2,759 | $20K | 5/21/2025 |
| Keithly Garnett | ▲ Buy | Open Market | 135 | $976 | 5/19/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 3,510 | $59K | 5/16/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 1,500 | $11K | 5/15/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 1,000 | $7K | 5/14/2025 |
| Keithly Garnett | ▲ Buy | Open Market | 90 | $631 | 5/13/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 990 | $7K | 5/13/2025 |
| Jim Delshad | ▲ Buy | Open Market | 5,000 | $36K | 5/12/2025 |
| Thomas C. Chen | ▲ Buy | Open Market | 400 | $3K | 5/12/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 1,400 | $10K | 5/12/2025 |
| Amir F. Heshmatpour | ▲ Buy | Open Market | 1,600 | $12K | 5/11/2025 |
| Jim Delshad | ▲ Buy | Open Market | 50 | $346 | 4/17/2025 |
| Keithly Garnett | ▲ Buy | Open Market | 300 | $2K | 4/15/2025 |
| Patrick Walters | ▼ Sell | Other | 1,231 | $0 | 3/26/2025 |
| Jim Delshad | ▲ Buy | Open Market | 50 | $802 | 3/26/2025 |
| Jim Delshad | ▲ Buy | Grant | 50,000 | $0 | 3/26/2025 |
| Keithly Garnett | ▼ Sell | Other | 687 | — | 3/26/2025 |
| Steven L. Giannotta | ▲ Buy | Grant | 50,000 | $0 | 3/26/2025 |
| Ming-Fu (alan) Chiang | ▲ Buy | Grant | 50,000 | $0 | 3/26/2025 |
| Ming-Fu (alan) Chiang | ▼ Sell | Other | 5,994 | $0 | 3/26/2025 |
| Amir F. Heshmatpour | ▼ Sell | Other | 3,996 | $0 | 3/26/2025 |
| Thomas C. Chen | ▼ Sell | Other | 4,076 | $0 | 3/26/2025 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 28, 2026
NeOnc Sets FDA Meeting for NEO212; Roth Starts Coverage
NeOnc Technologies has scheduled an in-person FDA End-of-Phase 1 meeting for November 17 regarding its NEO212 candidate. This regulatory milestone provides a clear next step for the company's development timeline. Additionally, Roth Capital initiated coverage with a price target of $20, which is at the top of the current analyst range.
NeOnc Sets FDA Meeting for NEO212; Roth Starts Coverage. NeOnc Technologies has scheduled an in-person FDA End-of-Phase 1 meeting for November 17 regarding its NEO212 candidate. This regulatory milestone provides a clear next step for the company's development timeline. Additionally, Roth Capital initiated coverage with a price target of $20, which is at the top of the current analyst range.